SWOG clinical trial number
SWOG-8517

Phase II Study of Platinum and Mitoxantrone in the Treatment of Metastatic Adenocarcinoma of the Prostate

Closed
Phase
Published
Abbreviated Title
Phase II Study of Platinum and Mitoxantrone in the Treatment of Metastatic Adenocarcinoma of the Prostate
Activated
02/10/1986
Closed
08/01/1987

Publication Information Expand/Collapse

1992

Phase II study of platinum and mitoxantrone in metastatic prostate cancer: A Southwest Oncology Group study.

CK Osborne;BA Blumenstein;ED Crawford;GR Weiss;Rm Bukowski;NR Larrimer EJC 28:477-478

1987

Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.

FJ Mather;RM Simon;DD Von Hoff Cancer Treat Rep 71(6):